ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include...
8 insider purchases on record · latest filing 2008-11-17.
Insiders have also filed 6 sale transactions at ARYX.